Access cutting-edge severe asthma treatment through this clinical trial at a research site in St Louis. Study-provided care at no cost to qualified participants.
Access severe asthma specialists in St Louis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related severe asthma treatment provided free
The objective of this study is to assess the potential for tezepelumab-treated patients (subcutaneous administration) to reduce maintenance therapy without loss of asthma control in adolescent and adults with severe asthma.. Study details include: 1. The study duration will be up to 72 weeks. 2. The treatment duration will be up to 68 weeks. 3. The visit frequency will be once every 4 weeks (Q4W).
Sponsor: AstraZeneca
Check if you qualify for this severe asthma clinical trial in St Louis, MO
If you're searching for severe asthma treatment options in St Louis, MO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our St Louis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced severe asthma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.